Similar Search Results

Trade, investment, innovation and their impact on access to medicines : an Asian perspective

Hsu, Locknie - 2016

"The last two decades have seen great economic change in Asia and this has impacted upon the vexed question of access to affordable healthcare and medicines in many Asian states. In this book Locknie Hsu examines the issue of access to medicines in Asia from a fresh perspective which embraces...

Persistent link: https://www.econbiz.de/10011403422

How do drug prices respond to a change from external to internal reference pricing? : evidence from a Danish regulatory reform

Kaiser, Ulrich; Mendez, Susan J. - 2015 - This version: January 5, 2015

We study the effects of a change in the way patient reimbursements are calculated on the prices of pharmaceuticals … analyze three therapeutic classes with different treatment durations and show that the reform led to substantial price … decreases for our lifelong treatment and to less substantial price reductions for our medium duration treatment while we do not …

Persistent link: https://www.econbiz.de/10010462523

Reference pricing of pharmaceuticals for Medicare : evidence from Germany, the Netherlands, and New Zealand

Danzon, Patricia Munch; Ketcham, Jonathan D. - In: Frontiers in health policy research 7 (2004), pp. 1-54

Persistent link: https://www.econbiz.de/10002227583

Moving towards an improved microsimulation model of the Australian pharmaceutical benefits scheme

Brown, Laurie; Abello, Annie; Phillips, Ben; Harding, Ann - In: The Australian economic review 37 (2004) 1, pp. 41-61

Persistent link: https://www.econbiz.de/10002179846

Drug price control in India : an overview

Shah, Mansi B.; Patel, Amit S. - In: Journal of pharmaceutical finance, economics & policy 12 (2003) 2, pp. 123-131

Persistent link: https://www.econbiz.de/10002185665

Drug pricing policy in Hungary

Vincze, Zoltán; Zelkó, Romána; Mészáros, Ágnes - In: Journal of pharmaceutical finance, economics & policy 12 (2003) 3, pp. 189-204

Persistent link: https://www.econbiz.de/10002185669

Germany's attempts to control drug prices and expenditures : Success or failure?

Dietrich, Eva Susanne - In: Journal of pharmaceutical finance, economics & policy 12 (2003) 3, pp. 205-234

Persistent link: https://www.econbiz.de/10002185670

The controls of price of medicines in Israel

Moshenson, Avi; Rice, Howard - In: Journal of pharmaceutical finance, economics & policy 12 (2003) 3, pp. 261-267

Persistent link: https://www.econbiz.de/10002185673

Regulierung des Marktes für verschreibungspflichtige Arzneimittel im internationalen Vergleich ; [Tab.]

Greß, Stefan; Niebuhr, Dea; Wasem, Jürgen - 2005 - 1. Aufl.

Persistent link: https://www.econbiz.de/10002956512

Generic script share and the price of brand-name drugs : the role of consumer choice

Rizzo, John A.; Zeckhauser, Richard - 2005

Persistent link: https://www.econbiz.de/10002957519